Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram

Abstract Background The thrombin generation (TG) assay is a feasible but labor‐intensive method for detecting global coagulation. It enables comprehensive assessment of anticoagulation, while drug‐specific assays assess only exposure. Traditionally, the Calibrated Automated Thrombogram (CAT) has bee...

Full description

Bibliographic Details
Main Authors: Tuukka A. Helin, Marja Lemponen, Riitta Lassila, Lotta Joutsi‐Korhonen
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
Online Access:https://doi.org/10.1002/rth2.12497
id doaj-ef75b56cf1274601a77cff309d1e0a53
record_format Article
spelling doaj-ef75b56cf1274601a77cff309d1e0a532021-04-10T11:22:15ZengWileyResearch and Practice in Thrombosis and Haemostasis2475-03792021-03-015343944610.1002/rth2.12497Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated ThrombogramTuukka A. Helin0Marja Lemponen1Riitta Lassila2Lotta Joutsi‐Korhonen3Department of Clinical Chemistry HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital Helsinki FinlandDepartment of Clinical Chemistry HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital Helsinki FinlandCoagulation Disorders Unit Helsinki University HospitalResearch Program Unit in Systems OncologyUniversity of Helsinki Helsinki FinlandDepartment of Clinical Chemistry HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital Helsinki FinlandAbstract Background The thrombin generation (TG) assay is a feasible but labor‐intensive method for detecting global coagulation. It enables comprehensive assessment of anticoagulation, while drug‐specific assays assess only exposure. Traditionally, the Calibrated Automated Thrombogram (CAT) has been used, however the ST Genesia (Diagnostica Stago) allows automated evaluation. Objective We aimed to observe coagulation using the ST Genesia and compare the data with those of CAT in anticoagulated patients. Patients and methods In total, 43 frozen‐thawed samples were studied using DrugScreen to assess direct oral anticoagulants (DOACs), warfarin, and low‐molecular‐weight heparin. Twenty samples (nine rivaroxaban, five apixaban, three warfarin, and three heparin) were also compared using CAT (5 pM tissue factor). Results TG reduction in DrugScreen depended on the specific drug and modestly correlated with DOAC levels (lag time R2 = 0.36; peak R2 = 0.50). The best correlation was observed with peak thrombin and rivaroxaban‐specified anti–activated factor X (anti‐Xa) activity (R2 = 0.60). When comparing ST Genesia with CAT, only the results for apixaban concorded (R2 = 0.97). Unlike CAT, ST Genesia yielded a normal endogenous thrombin potential (ETP) in 77% (24/31) activated factor X inhibitor cases, and it failed to give readouts at international normalized ratio (INR) ≥4.5 and at anti‐Xa ≥1.0 IU/mL. Conclusion The ST Genesia data did not correlate with CAT, but it was independently associated with INR, anti‐Xa, and DOAC concentrations. The lag time and peak responses were similar; the major differences were that ST Genesia showed no ETP effect of DOACs and failed to give readout at high INR or anti‐Xa activity.https://doi.org/10.1002/rth2.12497anticoagulantscalibrationheparinthrombin/analysiswarfarin
collection DOAJ
language English
format Article
sources DOAJ
author Tuukka A. Helin
Marja Lemponen
Riitta Lassila
Lotta Joutsi‐Korhonen
spellingShingle Tuukka A. Helin
Marja Lemponen
Riitta Lassila
Lotta Joutsi‐Korhonen
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram
Research and Practice in Thrombosis and Haemostasis
anticoagulants
calibration
heparin
thrombin/analysis
warfarin
author_facet Tuukka A. Helin
Marja Lemponen
Riitta Lassila
Lotta Joutsi‐Korhonen
author_sort Tuukka A. Helin
title Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram
title_short Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram
title_full Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram
title_fullStr Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram
title_full_unstemmed Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram
title_sort anticoagulated patients exhibit intact endogenous thrombin potential using st genesia unlike the calibrated automated thrombogram
publisher Wiley
series Research and Practice in Thrombosis and Haemostasis
issn 2475-0379
publishDate 2021-03-01
description Abstract Background The thrombin generation (TG) assay is a feasible but labor‐intensive method for detecting global coagulation. It enables comprehensive assessment of anticoagulation, while drug‐specific assays assess only exposure. Traditionally, the Calibrated Automated Thrombogram (CAT) has been used, however the ST Genesia (Diagnostica Stago) allows automated evaluation. Objective We aimed to observe coagulation using the ST Genesia and compare the data with those of CAT in anticoagulated patients. Patients and methods In total, 43 frozen‐thawed samples were studied using DrugScreen to assess direct oral anticoagulants (DOACs), warfarin, and low‐molecular‐weight heparin. Twenty samples (nine rivaroxaban, five apixaban, three warfarin, and three heparin) were also compared using CAT (5 pM tissue factor). Results TG reduction in DrugScreen depended on the specific drug and modestly correlated with DOAC levels (lag time R2 = 0.36; peak R2 = 0.50). The best correlation was observed with peak thrombin and rivaroxaban‐specified anti–activated factor X (anti‐Xa) activity (R2 = 0.60). When comparing ST Genesia with CAT, only the results for apixaban concorded (R2 = 0.97). Unlike CAT, ST Genesia yielded a normal endogenous thrombin potential (ETP) in 77% (24/31) activated factor X inhibitor cases, and it failed to give readouts at international normalized ratio (INR) ≥4.5 and at anti‐Xa ≥1.0 IU/mL. Conclusion The ST Genesia data did not correlate with CAT, but it was independently associated with INR, anti‐Xa, and DOAC concentrations. The lag time and peak responses were similar; the major differences were that ST Genesia showed no ETP effect of DOACs and failed to give readout at high INR or anti‐Xa activity.
topic anticoagulants
calibration
heparin
thrombin/analysis
warfarin
url https://doi.org/10.1002/rth2.12497
work_keys_str_mv AT tuukkaahelin anticoagulatedpatientsexhibitintactendogenousthrombinpotentialusingstgenesiaunlikethecalibratedautomatedthrombogram
AT marjalemponen anticoagulatedpatientsexhibitintactendogenousthrombinpotentialusingstgenesiaunlikethecalibratedautomatedthrombogram
AT riittalassila anticoagulatedpatientsexhibitintactendogenousthrombinpotentialusingstgenesiaunlikethecalibratedautomatedthrombogram
AT lottajoutsikorhonen anticoagulatedpatientsexhibitintactendogenousthrombinpotentialusingstgenesiaunlikethecalibratedautomatedthrombogram
_version_ 1721531886721826816